Evidence map›Paper›PMID 36840893›Full record

ArticleJournal of computer-aided molecular design2023

GPCRLigNet: rapid screening for GPCR active ligands using machine learning.

Jacob M Remington, Kyle T McKay, Noah B Beckage, Jonathon B Ferrell, Severin T Schneebeli, Jianing Li

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.International journal of molecular sciences · 2024
    Article
  11. Keras/TensorFlow in Drug Design for Immunity Disorders.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jacob M RemingtonDepartment of Chemistry, University of Vermont, Burlington, VT, 05405, USA.
Kyle T McKayDepartment of Chemistry, University of Vermont, Burlington, VT, 05405, USA.
Noah B BeckageDepartment of Chemistry, University of Vermont, Burlington, VT, 05405, USA.
Jonathon B FerrellDepartment of Chemistry, University of Vermont, Burlington, VT, 05405, USA.
Severin T SchneebeliDepartment of Chemistry, University of Vermont, Burlington, VT, 05405, USA.
Jianing LiDepartment of Chemistry, University of Vermont, Burlington, VT, 05405, USA. jianing-li@purdue.edu.

Funding

Robust Sequence-defined Nanocages with Protein-mimetic CavitiesR35GM147579 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Severin Thomas Schneebeli · 2022 to 2026
$1.9M
Structure, Mechanism, and Regulation of PACAP/VIP GPCR SubtypesR01GM129431 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI LI, JIANING · 2018 to 2022
$1.7M
NIGMS NIH HHS R01 GM129431NIGMS NIH HHS R35 GM147579
6 · The paper itself

Abstract

Molecules with bioactivity towards G protein-coupled receptors represent a subset of the vast space of small drug-like molecules. Here, we compare machine learning models, including dilated graph convolutional networks, that conduct binary classification to quickly identify molecules with activity towards G protein-coupled receptors. The models are trained and validated using a large set of over 600,000 active, inactive, and decoy compounds. The best performing machine learning model, dubbed GPCRLigNet, was a surprisingly simple feedforward dense neural network mapping from Morgan fingerprints to activity. Incorporation of GPCRLigNet into a high-throughput virtual screening workflow is demonstrated with molecular docking towards a particular G protein-coupled receptor, the pituitary adenylate cyclase-activating polypeptide receptor type 1. Through rigorous comparison of docking scores for molecules selected with and without using GPCRLigNet, we demonstrate an enrichment of potentially potent molecules using GPCRLigNet. This work provides a proof of principle that GPCRLigNet can effectively hone the chemical search space towards ligands with G protein-coupled receptor activity.

Indexed as

Machine LearningReceptors, G-Protein-CoupledHigh-Throughput Screening AssaysLigandsMolecular Docking SimulationLigandsReceptors, G-Protein-CoupledG protein-coupled receptorLigandMachine LearningMolecular DockingMolecular FingerprintNeural Network

Identifiers

PMID36840893
PMCPMC10379640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.